Frontiers in Bioengineering and Biotechnology,
Journal Year:
2025,
Volume and Issue:
12
Published: Jan. 8, 2025
Cancer
is
a
major
killer
threatening
modern
human
health
and
leading
cause
of
death
worldwide.
Due
to
the
heterogeneity
complexity
cancer,
traditional
treatments
have
limited
effectiveness.
To
address
this
problem,
an
increasing
number
researchers
medical
professionals
are
working
develop
new
ways
treat
cancer.
Bacteria
chemotaxis
that
can
target
colonize
tumor
tissue,
as
well
activate
anti-tumor
immune
responses,
which
makes
them
ideal
for
biomedical
applications.
With
rapid
development
nanomedicine
synthetic
biology
technologies,
bacteria
extensively
used
carriers
drug
delivery
tumors,
holds
promise
overcoming
limitations
conventional
cancer
treatment
regimens.
This
paper
summarizes
examples
anti-cancer
drugs
delivered
by
bacterial
carriers,
their
strengths
weaknesses.
Further,
we
emphasize
carrier
systems
in
clinical
translation.
Small Methods,
Journal Year:
2024,
Volume and Issue:
unknown
Published: April 1, 2024
Abstract
Sonodynamic
therapy
(SDT)
as
an
emerging
method
for
cancer
has
encountered
difficulty
in
insufficient
production
of
reactive
oxygen
species
(ROS),
especially
tumor
microenvironment
(TME)
with
elevated
antioxidants
and
hypoxic
conditions.
In
this
work,
the
authors
have
fabricated
heterostructured
manganese
dioxide
(MnO
2
)‐coated
BaTiO
3
nanoparticles
(BTO@M
NPs)
a
piezoelectric
sonosensitizer,
which
exhibits
capacity
remodeling
TME
multienzyme‐like
catalysis
boosting
SDT.
Benefitting
from
piezotronic
effect,
formation
p
‐
n
junction
between
MnO
BTO
built‐in
electric
field
band
bending
efficiently
promotes
separation
charge
carriers,
facilitating
generation
superoxide
anion
(•O
−
)
hydroxyl
radical
(•OH)
under
ultrasound
(US)
stimulation.
Moreover,
BTO@M
NPs
can
catalyze
overexpressed
hydrogen
peroxide
(H
O
to
produce
replenishing
gas
source
SDT,
also
deplete
antioxidant
glutathione
(GSH),
realizing
remodeling.
During
process,
reduced
Mn(II)
convert
H
into
•OH,
further
amplifying
cellular
oxidative
damage.
With
these
combination
effects,
versatile
exhibit
prominent
cytotoxicity
growth
inhibition
against
4T1
breast
cancer.
This
work
provides
feasible
strategy
constructing
high‐efficiency
sonosensitizers
Deleted Journal,
Journal Year:
2024,
Volume and Issue:
2(1)
Published: Jan. 1, 2024
Abstract
With
the
increasing
prevalence
of
infectious
diseases
caused
by
drug‐resistant
bacteria,
there
is
an
urgent
need
to
develop
innovative
therapies
alternative
antibiotics.
Among
these
alternatives,
aggregation‐induced
emission
(AIE)
photosensitizers
(PSs)
stand
out
with
their
integrated
imaging
and
therapeutic
functionalities,
allowing
for
early
monitoring
image‐guided
ablation
bacteria.
AIE
fluorescent
probes
unique
optical
properties
excel
in
selective
bacterial
imaging.
Furthermore,
AIE‐enabled
reactive
oxygen
species
(ROS)‐mediated
antibacterial
photodynamic
therapy
can
operate
on
multiple
targets
oxidize
Also,
as
they
are
able
specifically
target
PSs
ameliorate
limitations
small‐scale
action
ROS.
This
review
methodically
discusses
different
strategies
that
be
employed
using
targeting
including
sheltered
The
challenges
future
opportunities
this
emerging
field
also
briefly
discussed.
Advanced Science,
Journal Year:
2024,
Volume and Issue:
11(13)
Published: Jan. 22, 2024
Abstract
Although
immunogenic
cell
death
(ICD)
inducers
evidently
enhance
the
effectiveness
of
immunotherapy,
their
potential
is
increasingly
restricted
by
development
apoptosis
resistance
in
tumor
cells,
poor
immunogenicity,
and
low
T‐cell
immune
responsiveness.
In
this
study,
for
first
time,
piezoelectrically
catalyzed
Mg
2+
‐doped
hydroxyapatite
(Mg‐HAP)
nanoparticles,
which
are
coated
with
a
mesoporous
silica
layer
loaded
ONC201
as
an
agonist
to
specifically
target
receptor
DR5
on
ultimately
developing
Mg‐HAP@MS/ONC201
nanoparticle
(MHMO
NP)
system,
engineered.
Owing
its
excellent
piezoelectric
properties,
MHMO
facilitates
release
significant
amount
reactive
oxygen
species
Ca
within
effectively
promoting
upregulation
expression
inducing
necroptosis
overcome
resistance.
Concurrently,
released
microenvironment
promotes
CD8
+
T
activation
response
antitumor
reaction
induced
ICD.
Using
RNA‐seq
analysis,
it
elucidated
that
can
activate
NF‐κB
pathway
under
catalysis,
thus
M1‐type
macrophage
polarization.
summary,
dual‐targeting
therapy
system
targets
both
cells
catalysis
designed.
This
holds
substantial
advancements
immunotherapy.
Advanced Science,
Journal Year:
2025,
Volume and Issue:
unknown
Published: Feb. 8, 2025
Sonodynamic
therapy
(SDT)
represents
a
promising
approach
for
cancer
treatment.
Compared
to
photodynamic
therapy,
SDT
offers
increased
penetration
depth
and
higher
precision.
However,
the
practical
application
of
is
constrained
by
low
water
solubility,
poor
tumor
specificity,
metabolic
susceptibility
most
sonosensitizers.
Recent
research
has
explored
use
piezoelectric
materials
as
sonosensitizers
in
treatment
inhibition
bacterial
growth.
Upon
ultrasound
excitation,
separation
electron-hole
(e--h+)
pairs
occurs
within
material.
By
improving
crystal
structure
material
or
incorporating
other
nanoparticles
prevent
rapid
recombination
e--h+
pairs,
accumulates
charges
conduction
band
valence
band,
achieving
redox
potential
O2/·O2
-.
This
enables
serve
sonosensitizer,
leading
concept
termed
Sono-Piezo
Dynamic
Therapy
(SPDT).
review
aims
define
SPDT,
provide
systematic
overview
historical
development
SDT,
elucidate
mechanisms
which
act
Importantly,
various
will
be
discussed
terms
their
feasibility,
advantages,
disadvantages
sonosensitizers,
offering
new
perspectives
identifying
Frontiers in Bioengineering and Biotechnology,
Journal Year:
2025,
Volume and Issue:
12
Published: Jan. 8, 2025
Cancer
is
a
major
killer
threatening
modern
human
health
and
leading
cause
of
death
worldwide.
Due
to
the
heterogeneity
complexity
cancer,
traditional
treatments
have
limited
effectiveness.
To
address
this
problem,
an
increasing
number
researchers
medical
professionals
are
working
develop
new
ways
treat
cancer.
Bacteria
chemotaxis
that
can
target
colonize
tumor
tissue,
as
well
activate
anti-tumor
immune
responses,
which
makes
them
ideal
for
biomedical
applications.
With
rapid
development
nanomedicine
synthetic
biology
technologies,
bacteria
extensively
used
carriers
drug
delivery
tumors,
holds
promise
overcoming
limitations
conventional
cancer
treatment
regimens.
This
paper
summarizes
examples
anti-cancer
drugs
delivered
by
bacterial
carriers,
their
strengths
weaknesses.
Further,
we
emphasize
carrier
systems
in
clinical
translation.